<b>Results</b>: DUSP4 overexpression significantly enhanced HCC cell susceptibility to CAR-T cell killing in vitro and potentiated anti-PD-L1 efficacy in vivo, accompanied by TIME remodeling. Here, DUSP4 is linked to hepatocellular carcinoma.